Live feed
·
INSIDERFilingvia Quantisnow
Eyegate Pharmaceuticals, Inc. logo

SEC Form 4: Romano Sarah covered exercise/tax liability with 83 shares, decreasing direct ownership by 0.36% to 23,142 units

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
Eyegate Pharmaceuticals, Inc. logo
EYEG
Eyegate Pharmaceuticals, Inc.
Market cap
30-day
Sector
Health Care
Industry
Major Pharmaceuticals
Listed since
n/a
Follow EYEGFull EYEG profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EYEG (Eyegate Pharmaceuticals, Inc.) and more on Quantisnow.